Antiretroviral Activity of Semisynthetic Derivatives of Glycopeptide Antibiotics

Jan Balzarini, Christophe Pannecouque, Erik De Clercq, Andrey Y. Pavlov, Svetlana S. Printsevskaya, Marina I. Reznikova, M. N. Preobrazhenskaya

Journal of Medicinal Chemistry · 2003 · 61 citations · 24 references

Concepts

Abstract

A variety of semisynthetic derivatives of natural antibacterial glycopeptide antibiotics such as vancomycin, eremomycin, ristocetin A, teicoplanin A(2)-2, DA-40926, their aglycons, and also the products of their partial degradation with a destroyed or modified peptide core show marked anti-retroviral activity in cell culture. In particular, aglycon antibiotic derivatives containing various substituents of a preferably hydrophobic nature displayed activity against human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine sarcoma virus at a 50% inhibitory concentration in the lower micromolar (1-5 microM) concentration range while not being cytostatic against human lymphocytic cells at 250 microM or higher. The mode of anti-HIV action of the antibiotic aglycon derivatives could be ascribed to inhibition of the viral entry process.

References

24